SENATE ADOPTS HATCH MDR PRODUCT LIABILITY PROTECTION UNDER FDA REFORM BILL
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers would be protected from the presumption that an adverse event report to FDA represents an acknowledgment of liability under an amendment added to the Senate FDA reform bill (S 830) prior to passage of the bill Sept. 24.